White Paper

The ABCs of Drug Pricing

The ABCs of Drug Pricing

Drug pricing can be utterly complex. Starting from the drug’s research to selling at the pharmacy, numerous factors and variables impact the actual cost of a drug. Meanwhile, competition has spurred private players to seek their own cost benchmarking methods. 

So, what’s the best way to achieve realistic drug pricing amid an economy that is poised to reopen?

In this extract from a recent webcast by Wolters Kluwer, you will explore: 

  • Common terms and acronyms used in drug pricing (AWP, FUL, ASP, etc.)
  • Role of data on decision-making across the supply chain
  • Drug pricing trends and their impact on innovation, research, and cost

  This page is FastPass tested and is compliant with Microsoft Accessibility features.

Get Exclusive Access to the White Paper

By downloading this publication, you understand and agree that you are providing your personal information to Anteriad, LLC, and Anteriad may share your personal information with Wolters Kluwer, pursuant to Anteriad's Privacy Policy. Furthermore, Wolters Kluwer may use your personal information to provide you with marketing materials and contact you regarding its services, pursuant to Privacy Statement.